Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2026 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungenAcceptable Use
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to Reports
Fundraising

Mettler Toledo

Mettler Toledo Raises $40B in Public

1900 Polaris Parkway, Columbus, OH 43240January 1, 20242 min read
Employees
17200+

Mettler Toledo Raises $40B in Public


Mettler Toledo has successfully raised $40B in a Public at a $45B valuation led by Public.


Company Overview


Mettler Toledo is a Life Sciences company headquartered in 1900 Polaris Parkway, Columbus, OH 43240, founded in 1945 with 17200+ employees.


Laboratory equipment manufacturer


Fundraising Details


  • Amount Raised: $40B
  • Round Type: Public
  • Valuation: $45B
  • Date: 2024-01-01
  • Investors: Public

About Mettler Toledo


Laboratory equipment manufacturer The company is positioned in the Life Sciences sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 1900 Polaris Parkway, Columbus, OH 43240
  • Founded: 1945
  • Team Size: 17200+
  • Industry: Life Sciences

What This Means


This funding round demonstrates strong investor confidence in Mettler Toledo's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Life Sciences sector continues to attract significant investment as companies innovate to meet evolving market demands. Mettler Toledo's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $45B valuation marks an important milestone for Mettler Toledo, positioning the company among notable players in the Life Sciences industry.


Looking Ahead


With this new capital, Mettler Toledo is well-positioned to execute on its growth strategy and continue building innovative solutions in the Life Sciences space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Mettler Toledo, visit their headquarters at 1900 Polaris Parkway, Columbus, OH 43240.

Company Info

Headquarters
1900 Polaris Parkway, Columbus, OH 43240
Founded
1945
Team Size
17200+

Topics

Fundraising(2912)Public(771)Life SciencesMettler Toledo

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free